KORU Medical Systems, Inc.

NasdaqCM:KRMD Stock Report

Market Cap: US$99.2m

KORU Medical Systems Dividend

Dividend criteria checks 0/6

KORU Medical Systems does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.30
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

Feb 15
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Sep 21
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

Jul 14
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Sep 27
We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Oct 27
Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Aug 14
Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Jan 27
Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

KORU Medical Systems: A Razor & Razor Blade Story

Jan 11

Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Dec 29
Is Repro Med Systems, Inc. (NASDAQ:KRMD) Trading At A 50% Discount?

Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

Dec 03
Have Insiders Been Buying Repro Med Systems, Inc. (NASDAQ:KRMD) Shares This Year?

The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Dec 03
The Independent Chairman of the Board of Repro Med Systems, Inc. (NASDAQ:KRMD), R. Fletcher, Just Bought 77% More Shares

Repro Med Systems: Fair View Of The Fundamentals

Nov 18

Repro Med Systems, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 05

Repro Med Systems EPS misses by $0.01, misses on revenue

Nov 03

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if KRMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if KRMD's dividend payments have been increasing.


Dividend Yield vs Market

KORU Medical Systems Dividend Yield vs Market
How does KRMD dividend yield compare to the market?
SegmentDividend Yield
Company (KRMD)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Medical Equipment)1.8%
Analyst forecast in 3 Years (KRMD)n/a

Notable Dividend: Unable to evaluate KRMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate KRMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate KRMD's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as KRMD has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.